Merge completes Amicas merger

Merge Healthcare successfully closed the merger agreement with Amicas Wednesday, creating a medical imaging software and health IT technologies provider.

With a combined customer base of approximately 1500 hospital and 2200 outpatient sites in the U.S., and distribution agreements in more than 35 countries for outpatient imaging businesses, the newly combined company will offer technologies for revenue cycle management, RIS, referring physician connectivity technologies, radiology PACS and computer-aided detection technologies.

For hospitals, Merge will offer interoperability and health IT solutions, as well as departmental technology for cardiology, radiology and peri-operative departments. In addition, the new company will deliver its product set internationally.

This transaction completes the definitive merger agreement between Merge and Amicas, as of late February, under which a subsidiary of Merge acquired all of the outstanding shares of Amicas common stock for $6.05 per share. To finance the transaction, Merge placed $200 million senior secured notes due 2015, and completed a private placement of preferred and common stock of $41.75 million.

In conjunction with the completion of the transaction, the stock of Amicas has ceased trading on the Nasdaq Stock Market.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup